ストックスクリーナーアプリを入手
0.9342
2.29%
0.0209
アフターアワーズ：
.96
0.0258
+2.76%
前日終値:
$0.9133
開ける：
$0.9208
24時間の取引高:
3.48M
Relative Volume:
0.80
時価総額：
$275.36M
収益：
$55.87M
当期純損益:
$-77.60M
株価収益率:
-2.619
EPS:
-0.3567
ネットキャッシュフロー:
$-79.46M
1週間 パフォーマンス:
+23.69%
1か月 パフォーマンス:
-0.48%
6か月 パフォーマンス:
-40.12%
1年 パフォーマンス:
-18.05%
1日の値動き範囲:
$0.901
$0.9469
1週間の範囲:
$0.82
$1.05
52週間の値動き範囲:
$0.5277
$3.0699
Invivyd Inc Stock (IVVD) Company Profile
Compare IVVD vs VRTX, REGN, MRNA, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
0.9342 | 275.36M | 55.87M | -77.60M | -79.46M | -0.3567 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-22 | 開始されました | BTIG Research | Buy |
| 2025-11-25 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2025-10-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-04-05 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-03-26 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Invivyd Inc (IVVD) 最新ニュース
Invivyd Inc (IVVD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Invivyd stock falls 8 percent as earnings miss estimates - AD HOC NEWS
Invivyd, Inc.(NasdaqGM: IVVD) added to S&P Global BMI Index - marketscreener.com
3 Small-Cap Biotechs With Binary Catalysts on the Calendar - marketbeat.com
INVIVYD INC (IVVD) Stock Chart - ChartMill
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
Invivyd to Participate in Upcoming September Investor Conferences - manilatimes.net
Invivyd management will join two live webcast chats in September - Stock Titan
Invivyd stock holds steady as investors watch recent trial progress - ad-hoc-news.de
IVVD News | INVIVYD INC (NASDAQ:IVVD) - ChartMill
Invivyd Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout - Fierce Biotech
Invivyd names chairman Marc Elia as chief executive, ahead of pivotal VYD2311 data - The Pharma Letter
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Invivyd stock falls as investors await VYD2311 data - ad-hoc-news.de
Invivyd (IVVD) Edges Higher to $0.81, Testing Key $0.85 Resistance ZoneBull Pennant - dars.gov.et
Director at Invivyd (IVVD) granted 100K stock options - Stock Titan
No Invivyd (NASDAQ: IVVD) shares listed in company director's ownership filing - Stock Titan
Invivyd appoints Marc Elia CEO amid board reshuffle - The Globe and Mail
New multi-million-share option grant for Invivyd (IVVD) CEO - stocktitan.net
Invivyd, Inc. Announces Board Appointments - marketscreener.com
New Haven COVID drugmaker names new CEO ahead of key trial results - Hartford Business Journal
Invivyd Names Chairman Marc Elia as CEO - marketscreener.com
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY - The Manila Times
Invivyd Names Marc Elia CEO, Adds New Independent Director as VYD2311 Phase 3 Studies Near Completion - Quiver Quantitative
Invivyd (IVVD) gives its new CEO rich equity and a potential 0.5%–1.5% payout on any sale worth at least $5B, as Phase 3 COVID antibody data near. - Stock Titan
Cantor Fitzgerald reiterates Invivyd stock rating on COVID trends By Investing.com - Investing.com UK
Cantor Fitzgerald reiterates Invivyd stock rating on COVID trends - Investing.com
Invivyd (IVVD) EPS and Revenue: The Bottom-Line Figure Trails Its Comparison in Latest Trading; Share Response - careplusvn.com
IVVD|Invivyd Inc|Price:0.997|Chg%:+0.046 - TradingKey
Invivyd (IVVD) Results Check: Profit Per Share Falls Below Its Benchmark on the Day; Price Move: The Stock Ends Up 2.65%Earnings Sentiment Score - vinanet.vn
Invivyd Stock (IVVD) Opinions on Upcoming Phase 3 Results - Moomoo
Invivyd (IVVD) Q1 2026 Results: The EPS Result Is Below Expectation; Closing Reaction: Shares Finish 10.53% Higher for the Current SessionEPS Revision Trend - vinanet.vn
FY2026 EPS Estimates for Invivyd Increased by HC Wainwright - MarketBeat
Invivyd CSO Robert Allen III sells $29,295 in stock By Investing.com - Investing.com South Africa
Invivyd chief legal officer Jill Andersen sells $52,780 in shares By Investing.com - Investing.com Australia
Invivyd CCO Timothy Lee sells $31,670 in shares By Investing.com - Investing.com Nigeria
Invivyd CFO William Duke sells $31,670 in company stock By Investing.com - Investing.com South Africa
Invivyd CFO William Duke sells $31,670 in company stock - Investing.com
Invivyd CHRO Julie Green sells $31,670 in company stock - Investing.com India
Invivyd CSO Robert Allen III sells $29,295 in stock - Investing.com
Invivyd chief legal officer Jill Andersen sells $52,780 in shares - Investing.com
Invivyd CCO Timothy Lee sells $31,670 in shares - Investing.com
Insider Selling: Invivyd (NASDAQ:IVVD) Insider Sells 18,425 Shares of Stock - MarketBeat
Insider Selling: Invivyd (NASDAQ:IVVD) Insider Sells $25,793.04 in Stock - MarketBeat
Invivyd (NASDAQ:IVVD) Insider Sells $26,824.32 in Stock - MarketBeat
Invivyd (IVVD) Closing Review: Moves 17.23% Up to $0.87; Current Setup: $0.83 and $0.91 Define the Nearby Reference Levels in Latest TradingLow Volatility Picks - vinanet.vn
Invivyd (IVVD) officer sells 37,256 and 30,706 shares under 10b5-1 plan - Stock Titan
H.C. Wainwright reiterates Invivyd stock rating on trial progress By Investing.com - Investing.com Canada
Invivyd (IVVD) Rises 2.72% to $0.74 as Buyers Defend Key Support at $0.70Rectangle Pattern - vinanet.vn
H.C. Wainwright reiterates Invivyd stock rating on trial progress - Investing.com
Invivyd Inc (IVVD) 財務データ
収益
当期純利益
現金流量
EPS
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):